![Page 1: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/1.jpg)
Seronegative Spondyloarthropathies
![Page 2: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/2.jpg)
Goals of the Lecture
• Introduce the spondyloarthropathies• Recognize AS as the prototypic
disease• Recognize common clinical and
radiologic features and specific features including:
• Epidemiology• Diagnosis• Treatment
![Page 3: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/3.jpg)
Seronegative Spondyloarthropathies
![Page 4: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/4.jpg)
Seronegative spondyloarthropathies (SNSA):
A family of diseases• Ankylosing
Spondylitis• Reiter’s syndrome/
Reactive arthritis• IBD arthropathy• Psoriatic arthropathy
(SNSA variant)• Undifferentiated
spondyloarthropathy• Juvenile onset SNSA
![Page 5: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/5.jpg)
SNSA: Group characteristics
• Propensity to affect spine, peripheral joints, and periarticular structures
• Characteristic extraarticular features
• Absence of RF and ANA• Association with HLA B27
![Page 6: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/6.jpg)
SNSA: Group pathology
• Sacroiliitis– Osteopenia– Erosions
• Peripheral arthritis– Synovial hyperplasia– Pannus– Lymphoid infiltration
• Enthesitis– Inflammation at
tendinous insertions
![Page 7: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/7.jpg)
Causes of sacroiliitis
• Seronegatives– AS– Reiter’s– Psoriatic arthritis– IBD– SAPHO– Acne-associated– Intestinal bypass
• Infections– Pyogenic infections– Tuberculosis– Brucellosis– Whipple’s
• Others– Paraplegia– Sarcoidosis– Hyperparathyroidis
m
![Page 8: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/8.jpg)
Ankylosing spondylitis: Prototype SNSA
• Systemic inflammatory – Sacroiliitis is hallmark
• X-ray evidence needed for original and modified NY criteria
– Clinical spectrum wider than symptomatic sacroiliitis
– Atypical
![Page 9: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/9.jpg)
AS: Diagnosis
• Diagnostic Criteria– Highly sensitive at early stage of
disease
• Classification Criteria– Deals with groups of patients – NOT individual patients– Primarily for epidemiologic purposes
![Page 10: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/10.jpg)
Grading sacroiliitis
• Grading of radiographsNormal 0
Suspicious 1
Minimal sacroiliitis 2
Moderate sacroiliitis 3
Ankylosis 4
![Page 11: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/11.jpg)
Ankylosing spondylitis(Modified New York classification criteria)
1. LBP at rest for >3 months• improved with exercise• not relieved by rest
2. Limitation of lumbar spine3. Decreased chest expansion4. Bilateral sacroiliitis grade 2-45. Unilateral sacroiliitis grade 3-4
Definite AS if criterion 4 and any other criteria is fulfilled
![Page 12: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/12.jpg)
Ankylosing spondylitis: Clinical features
• Onset in late adolescence/ early adulthood
• After age 45 is uncommon
• Much more common in men • M:F 3:1• Clinical/xray features evolve more slowly
in women
• Skeletal vs. extraskeletal features
![Page 13: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/13.jpg)
AS :Skeletal features
• Axial (back pain)– sacroiliitis– spondylitis
• Hips/shoulders• Enthesitis• Osteoporosis• Spinal fractures
![Page 14: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/14.jpg)
Ankylosing spondylitisvs. mechanical LBP
• Inflammatory/ spondylitic back pain1. Onset prior to age
402. Insidious onset3. Persistence at least
3 months4. Morning stiffness5. Improvement with
exercise
Need 4/5 criteria
![Page 15: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/15.jpg)
Inflammatory questions
– Sensitivity 95-100% – False + 10-15%
• mechanical back pain and healthy athletes
• low prevalence of AS in population (1-2%)
– Positive predictive value is low• 10% false positive
![Page 16: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/16.jpg)
AS: Peripheralskeletal features
• Hip and shoulder involvement– May be first
symptom– Up to 1/3 patients– More common in
juvenile (<16) onset– Flexion contractures
at hips
![Page 17: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/17.jpg)
AS: Peripheral skeletal features
• Other peripheral joints– Infrequent– Often asymmetric– Transient– Rarely erosive– Resolves without
residual deformity
![Page 18: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/18.jpg)
AS: Enthesitis
• Enthesitis– Extra-articular or juxta-articular
bony pain• Costosternal junctions• Spinous processes• Iliac crests• Greater trochanters• Ischial tuberosities• Tibial tubercles• Achilles tendon insertions• Plantar fascia insertion• Pes anserinus• Epicondylus humeri
lateralis
![Page 19: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/19.jpg)
![Page 20: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/20.jpg)
![Page 21: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/21.jpg)
Extraskeletal manifestations
• A ortic insufficiency and other cardiac pathology• N eurologic (atlantoaxial subluxation, Cauda equina)• K idney (secondary amyloidosis, chronic prostatitis)
• S pine (cervical fracture, spinal stenosis)• P ulmonary (apical lobe fibrosis, restrictive disease)• O cular (anterior uveitis)• N ephropathy (IgA)• D iscitis
![Page 22: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/22.jpg)
AS: Extraskeletal manifestations
• Eye- acute anterior uveitis (25-30%)• Heart- ascending aortitis, AR (3-
10%), conduction abnormalities (3%)• Pulmonary- apical fibrosis (rare)• Neurologic- fracture/dislocation.
subluxations, cauda equina syndrome
![Page 23: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/23.jpg)
AS: Iritis
• Acute anterior uveitis/iritis/ iridocyclitis
• Most common ES• 25-30%• Unilateral• Recurrent
• Symptoms• Pain• Lacrimation• Photophobia• Blurry vision
![Page 24: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/24.jpg)
AS: Physical examination
• Limited range of motion (especially hyperextension, lateral flexion, or rotation)
• Spasm/soreness of paraspinal muscles
• Positive Schober’s test• Loss of lumbar lordosis• Sacroiliac discomfort
![Page 25: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/25.jpg)
Patrick’s and Gaenslen’s tests
![Page 26: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/26.jpg)
Office measurement
![Page 27: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/27.jpg)
Wiki
• The Dimples of Venus (also known as booty dimples, back dimples, or butt dimples) are sagittally symmetrical indentations sometimes visible on the human lower back, just superior to the gluteal cleft. They are directly superficial to the two sacroiliac joints, the sites where the sacrum attaches to the ilium of the pelvis.
• The term "Dimples of Venus", while informal, is an historically accepted name within the medical profession for the superficial topography of the sacroiliac joints. The Latin name is fossae lumbales laterales ('lateral lumbar indentations'). These indentations are created by a short ligament stretching between the posterior superior iliac spine and the skin.
• Booty dimples are rapidly gaining cultural momentum as a feature men find attractive in women and other men.
![Page 28: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/28.jpg)
Wiki
• The dimples of Venus (also known as back dimples) are sagittally symmetrical indentations sometimes visible on the human lower back, just superior to the gluteal cleft. They are directly superficial to the two sacroiliac joints, the sites where the sacrum attaches to the ilium of the pelvis.
• The term "dimples of Venus", while informal, is a historically accepted name within the medical profession for the superficial topography of the sacroiliac joints. The Latin name is fossae lumbales laterales ("lateral lumbar indentations"). These indentations are created by a short ligament stretching between the posterior superior iliac spine and the skin. They are thought to be genetic.
• There are other deep-to-superficial skin ligaments, such as "Cooper's ligaments", which are present in the breast and are found between the pectoralis major fascia and the skin.
• There is another use for the term "Dimple of Venus" in surgical anatomy. These are two symmetrical indentations on the posterior aspect of sacrum which contain a venous channel too. They are used as a landmark for finding the superior articular facets of the sacrum as a guide to place sacral pedicle screws in spine surgery[1].
![Page 29: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/29.jpg)
1="Vertebra prominens" Spinous process of C7
2= 2nd Lumbar vertebra
3= L4-5 inter vertebral space
4= Iliac crests
5= Dimples of Venus / Sacroiliac joints / Booty Dimples
![Page 30: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/30.jpg)
Office measurement
![Page 31: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/31.jpg)
Don’t Be Fooled!
![Page 32: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/32.jpg)
AS: Laboratory findings
• Elevated ESR (75%)• Elevated CRP• ANA and RF negative• NC/NC anemia (15%)• HLA B27• No diagnostic or pathognomic
tests!
![Page 33: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/33.jpg)
HLA-B27: Disease Associations
Disease Association
Ankylosing spondylitis >90%
Reiter’s syndrome 80%
Reactive arthritis 85%
Inflammatory bowel disease 50%
Psoriatic arthritis- spondylitis 50%
- peripheral arthritis
15%
Whipple’s disease 30%
![Page 34: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/34.jpg)
HLA B27 and AS in Caucasian populations
• HLA B27 in Americans 8-14%• HLA B27 in African Americans 3% • HLA B27 in AS patients >90%• Prevalence of AS in population 1%• Prevalence of AS in HLA B27+
individuals 2%• Prevalence of AS in B27+ relatives 20%• Prevalence of AS in B27- relatives 0%
![Page 35: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/35.jpg)
AS: Radiologic features
• Sacroiliac – Bilateral, symmetric involvement (i.e.
erosions, sclerosis, pseudowidening, ossification)
• Spine– “Shiny corners”, squaring of the vertebra,
ossification of the annulus fibrosus, ankylosis
• Hip – Symmetric concentric joint narrowing
![Page 36: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/36.jpg)
AS: Radiographic findings
• SI joint- symmetric– Pronounced on iliac
side• Erosions/sclerosis
– ‘Postage stamp’ serrations
– Pseudowidening
![Page 37: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/37.jpg)
www.mdconsult.com/das/book/0/view/1807/I4-u1....
![Page 38: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/38.jpg)
More sensitive than XRAY
• MRI
• CT
![Page 39: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/39.jpg)
![Page 40: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/40.jpg)
Late sacroiliac changes
• Calcification,interosseous bridging, and ossification
• Bony ankylosis
• Osteoporosis
![Page 41: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/41.jpg)
ASRadiographic findings
• Vertebral Column– Squaring of
vertebrae
![Page 42: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/42.jpg)
Skeletal manifestations
• Syndesmophytes– Ossification of
the outer layers of the annulus fibrosis
– Sharpey’s fibers
– Vertical
![Page 43: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/43.jpg)
Osteophyte Vs. Syndesmophyte
![Page 44: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/44.jpg)
Late axial disease
BAMBOO
![Page 45: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/45.jpg)
AS: Radiographic findings• Enthesitis
– Bony erosions– Osteitis (whiskering)
of insertions• Ischial tuberosities• Iliac crest• Calcani• Femoral
trochanters• Spinous processes
![Page 46: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/46.jpg)
AS: Treatment
• Main objectives– Patient education– Early diagnosis– Control pain and suppress inflammation– Daily exercises– Surgical measures (i.e. hip arthroplasty)– Vocational support
![Page 47: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/47.jpg)
AS:Treatment
• NSAIDs- pain and stiffness• Sulfasalazine/MTX- peripheral
arthritis• Anti-TNF agents- axial and
peripheral disease• Oral corticosteroids- little role• Local corticosteroids-
recalcitrant enthesopathy
![Page 48: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/48.jpg)
Etanercept in AS (% ASAS Response Week 12)
Davis J, et al, Arthritis Rheumatism 2003
0
10
20
30
40
50
60
70
80
90
100
ASAS 20 ASAS 50 ASAS 70
Placebo (n=138)Etanercept (n=139)
![Page 49: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/49.jpg)
Infliximab in AS(% ASAS Response at 24 weeks)
van der Heijde D, et al, Arthritis Rheumatism 2005
0
1020
3040
5060
7080
90100
ASAS 20 ASAS 40
placebo (n=78)Infliximab (n=201)
![Page 50: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/50.jpg)
AS: Summary
Age at onset Young adultsSex ratio 3:1 (males to
females)Axial disease Virtually 100%Sacroiliitis SymmetricPeripheral joint 25%Eye involvement 25%Infectious triggers Unknown
![Page 51: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/51.jpg)
Case scenario 1
• 35 year old male • 6 months of low back
stiffness and pain– Improves with
exercise• Painful swelling at
Achilles insertion • Urethral discharge
prior to symptoms
![Page 52: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/52.jpg)
Physical Exam
![Page 53: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/53.jpg)
Reactive arthritis: Clinical triad
1. Conjunctivitis2. Urethritis/cervicitis3. Arthritis
![Page 54: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/54.jpg)
Reactive arthritis: Epidemiology
• Incidence– Postdysenteric: 9/602 sailors– Olmsted county, MN: 3.5 cases/100,000
• Age of onset– 20-30s (5-80)
• Gender– 5:1 male to female– Postvenereal (males >> females)– Postdysenteric (males=females)
![Page 55: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/55.jpg)
Reactive arthritis: Joint disease
• Onset 1-4 weeks after exposure• Asymmetric, additive, and
ascending oligoarthritis• Lower extremity typical• Dactylitis (“sausage digits”)• Axial symptoms at onset (50%)
![Page 56: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/56.jpg)
Reactive arthritis: Clinical features
• Ocular– Uveitis, conjunctivitis,
keratitis
• Mucocutaneous– Oral ulcerations,
circinate balanitis, keratoderma
• Others– Fevers, cardiac (AR,
conduction abnormalities)
![Page 57: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/57.jpg)
Reactive arthritis: Triggers
• Enteric pathogens– Shigella flexneri– Salmonella
typhimurium– Yersinia
enterocolitica– Campylobacter
jejuni
• Urogenital pathogens– Chlamydia
trachomatis– Ureaplasma
urealyticum
![Page 58: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/58.jpg)
Reactive arthritis: Labs
• Elevated ESR and CRP• Thrombocytosis, NC/NC anemia• Remember HIV
• ALL ARE NON-SPECIFIC
![Page 59: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/59.jpg)
Reactive arthritis: Therapy
• NSAIDs• Long acting indomethacin• Systemic glucocorticoids• DMARDs• TNF blockers• Prolonged antibiotics ??
![Page 60: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/60.jpg)
Reactive arthritis: Summary
Age at onset Young adultsSex ratio Mostly maleAxial disease 50%Symmetry AsymmetricPeripheral joints >90%Eye involvement CommonSkin/nail findings Common
![Page 61: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/61.jpg)
Case scenario 2
• 45 year old male • 6 months of low back
stiffness and pain– Improves with
exercise• New rash on elbows
and knees • Tender, swollen
fingers and toes
![Page 62: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/62.jpg)
![Page 63: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/63.jpg)
Psoriatic arthritis (PSA)
Five types1. Oligoarticular (>50%)
2. RA variant (25%)3. DIP only (5-10%)4. Arthritis mutilans
(5%)5. Back disease (20-
40%)
![Page 64: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/64.jpg)
Psoriatic arthritis (PSA):Radiology
• Fusiform• Normal
mineralization• Joint space loss• Pencil in cup• Bone proliferation
![Page 65: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/65.jpg)
![Page 66: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/66.jpg)
Psoriatic arthritis: Summary
Age at onset Young adultsSex ratio EqualAxial disease 20%Symmetry AsymmetricPeripheral joint 95%Eye involvement OccasionalSkin/nail disease Virtually 100%
![Page 67: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/67.jpg)
Case scenario 3
• 35 year old male • 6 months of low back
stiffness and pain– Improves with
exercise
• New onset diarrhea • Painful sores on shins
![Page 68: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/68.jpg)
![Page 69: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/69.jpg)
Inflammatory bowel disease: Relationship to bowel
symptoms• Bowel symptoms precede or
coincide with joint symptoms in vast majority
• BUT, in 5-10% joints symptoms preceded bowel disease
• In UC, removal of colon usually eliminates peripheral disease
![Page 70: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/70.jpg)
Inflammatory bowel disease: Axial disease
• Prevalence– Sacroiliitis 10-20%– Spondylitis 7-12%
• Female to male ratio: 1:1• Onset of axial involvement does
not correlate with IBD• Removal of bowel does not affect
axial disease
![Page 71: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/71.jpg)
Inflammatory bowel disease:
Peripheral arthritis• Prevalence: 17-20% (higher in
Crohn’s)• Pattern: Pauciarticular,
asymmetric, frequently transient• Joints involved: Large lower
extremity joints (usually not destructive)
• Soft tissue: enthesopathy, clubbing, sausage digits
![Page 72: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/72.jpg)
IBD: Summary
Age of onset Young adultsSex ratio EqualAxial disease <20%Symmetry SymmetricPeripheral joints FrequentEye involvement OccasionalSkin/nail findings Uncommon
![Page 73: Seronegative Spondyloarthropathies. Goals of the Lecture Introduce the spondyloarthropathies Recognize AS as the prototypic disease Recognize common clinical](https://reader030.vdocument.in/reader030/viewer/2022032606/56649eb55503460f94bbe68d/html5/thumbnails/73.jpg)